[{"NetIncomeLoss_4_FY_USD":-73812000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":217000.0,"Depreciation_4_FY_USD":900000.0,"StockIssuedDuringPeriodValueNewIssues_4_FY_USD":114283000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_4_FY_USD":19.51,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4_FY_shares":1604470.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_FY_USD":5000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_4_FY_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":5588000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":-15417000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":1244000.0,"AssetsCurrent_0_FY_USD":177492000.0,"DeferredTaxAssetsTaxCreditCarryforwardsOther_0_FY_USD":1400.0,"OtherNoncashIncomeExpense_4_FY_USD":17000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_4_FY_USD":135592000.0,"DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0_FY_USD":118200000.0,"IncomeTaxReconciliationOtherAdjustments_4_FY_USD":443000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":4438000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":114283000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.001,"OperatingLeaseRightOfUseAsset_0_FY_USD":2232000.0,"ShareBasedCompensation_4_FY_USD":10427000.0,"OtherComprehensiveIncomeLossNetOfTax_4_FY_USD":-123000.0,"Assets_0_FY_USD":183445000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_FY_USD":15930000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":77793000.0,"UnrecognizedTaxBenefits_0_FY_USD":1092000.0,"CommonStocksIncludingAdditionalPaidInCapital_0_FY_USD":336508000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4_FY_USD":135995000.0,"DeferredTaxAssetsTaxCreditCarryforwardsResearch_0_FY_USD":6881000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":1208000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_4_FY_USD":288000.0,"CommonStockSharesIssued_0_FY_shares":33017000.0,"IncomeTaxReconciliationStateAndLocalIncomeTaxes_4_FY_USD":-4886000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":25000.0,"CommitmentsAndContingencies_0_FY_USD":null,"DeferredTaxLiabilitiesLeasingArrangements_0_FY_USD":1358000.0,"ResearchAndDevelopmentExpense_4_FY_USD":56998000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_FY_USD":14.42,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":5776000.0,"IncomeTaxReconciliationTaxSettlementsForeign_4_FY_USD":215000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0_FY_USD":1932000.0,"IncomeTaxExpenseBenefit_4_FY_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":-2043000.0,"DeferredTaxAssetsOperatingLossCarryforwardsForeign_0_FY_USD":1600000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":2723000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_FY_USD":871000.0,"IncomeTaxReconciliationChangeInEnactedTaxRate_4_FY_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":114571000.0,"DeferredCompensationLiabilityClassifiedNoncurrent_0_FY_USD":23000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_4_FY_USD":0.0,"RestrictedCash_0_FY_USD":500000.0,"CashCashEquivalentsAndShortTermInvestments_0_FY_USD":170900000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":30448000.0,"GeneralAndAdministrativeExpense_4_FY_USD":18026000.0,"DepreciationAndAmortization_4_FY_USD":948000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_FY_USD":11.02,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"OperatingLeaseLiability_0_FY_USD":4849000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_FY_USD":14.42,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":-123000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":4014000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":93087000.0,"OtherAssetsNoncurrent_0_FY_USD":40000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-73935000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_4_FY_USD":0.0,"OtherAssetsCurrent_0_FY_USD":1024000.0,"Liabilities_0_FY_USD":14526000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"InterestReceivableCurrent_0_FY_USD":113000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4_FY_USD":12.83,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":52761000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":22242000.0,"DeferredTaxAssetsGross_0_FY_USD":51629000.0,"CommonStockSharesOutstanding_0_FY_shares":33001000.0,"RestrictedCashNoncurrent_0_FY_USD":500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_FY_shares":4421533.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":2558000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":30000.0,"OperatingLossCarryforwards_0_FY_USD":33994000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":-73812000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":10427000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-62027000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":1173000.0,"LiabilitiesCurrent_0_FY_USD":10489000.0,"NonoperatingIncomeExpense_4_FY_USD":1141000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":93587000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":6612000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":3181000.0,"DeferredTaxAssetsInProcessResearchAndDevelopment_0_FY_USD":4231000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_FY_USD":11766000.0,"CapitalExpendituresIncurredButNotYetPaid_4_FY_USD":6000.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"PrepaidInsurance_0_FY_USD":693000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-167614000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_4_FY_USD":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":691000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_4_FY_shares":170696.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_FY_Security":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_FY_USD":15930000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":369000.0,"ProceedsFromStockOptionsExercised_4_FY_USD":288000.0,"NumberOfOperatingSegments_4_FY_Segment":1.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_FY_shares":1957407.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_FY_shares":4421533.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":3233000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4_FY_USD":1.68,"PreferredStockValue_0_FY_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4_FY_USD":19.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4_FY_pure":0.0,"InvestmentIncomeInterest_4_FY_USD":991000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4_FY_USD":2500000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":183445000.0,"OperatingIncomeLoss_4_FY_USD":-74953000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":71000.0,"CommonStockSharesAuthorized_0_FY_shares":200000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":1623000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":1280000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":927000.0,"DeferredTaxAssetsNet_0_FY_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_4_FY_USD":0.0,"ShortTermInvestments_0_FY_USD":77793000.0,"PreferredStockSharesAuthorized_0_FY_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_FY_USD":26900000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":227000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":-71769000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":77768000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":186000.0,"StockholdersEquity_0_FY_USD":168919000.0,"OtherLiabilitiesCurrent_0_FY_USD":835000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":10427000.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-2.42,"OperatingExpenses_4_FY_USD":75024000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":835000.0,"DeferredTaxLiabilitiesOther_0_FY_USD":132000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":5739000.0,"DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_0_FY_USD":124100000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":50872000.0,"DeferredTaxAssetsLiabilitiesNet_0_FY_USD":50872000.0,"IncomeTaxReconciliationTaxCreditsResearch_4_FY_USD":2597000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210330"}]